Literature DB >> 12404708

Diabetes is not a risk factor for tardive dyskinesia: a retrospective observational study.

Michele Raja1, Antonella Azzoni.   

Abstract

The aim of this observational study was to compare the prevalence of tardive dyskinesia (TD) in diabetic and non diabetic patients. We compared 34 diabetic patients with 34 non diabetic controls, matched by sex, age and time of admission, who had received a complete neuropsychiatric evaluation and who had been exposed to antidopaminergic treatment for at least 3 months. Among them, 8 of 24 diabetic (33.3%) and 6 of 15 (40.0%) non diabetic patients presented TD. The prevalence of TD in the diabetic group is numerically lower than in the controls but the difference is not statistically significant (chi(2) = 0.006; fd = 1; p = 0.937). These results suggest that diabetes is unlikely to play a major role in the pathogenesis of TD. Copyright 2002 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12404708     DOI: 10.1002/hup.354

Source DB:  PubMed          Journal:  Hum Psychopharmacol        ISSN: 0885-6222            Impact factor:   1.672


  2 in total

1.  Tardive akathisia related to the anti-hypertensive agent Sevikar-a case report.

Authors:  Men-Ting Hsieh; Pao-Yen Lin; Chia-Jen Tsai; Chiung-Chih Chang; Yu Lee
Journal:  BMC Pharmacol Toxicol       Date:  2017-06-05       Impact factor: 2.483

2.  Tardive and spontaneous dyskinesia incidence in the general population.

Authors:  Ray M Merrill; Joseph L Lyon; Paul M Matiaco
Journal:  BMC Psychiatry       Date:  2013-05-28       Impact factor: 3.630

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.